Skip to Main Content

Paper Details

Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers.
Mol Cancer Ther
30
2019
Author NameAffiliation
Matthew J MeyerNovartis Institute of Biomedical Research
Serena J SilverNovartis Institute of Biomedical Research
Giordano CaponigroNovartis Institute of Biomedical Research
Peter S HammermanNovartis Institute of Biomedical Research
Peter S HammermanNovartis Institute of Biomedical Research
  • 1 - 5

Datasets

Release 1.2